TITLE

New CCB gains approval

PUB. DATE
February 1995
SOURCE
Drug Topics;2/20/95, Vol. 139 Issue 4, p8
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports that Miles has received approval from the US Food & Drug Administration (FDA) to market nisoldipine for the treatment of hypertension.
ACCESSION #
9503312819

 

Related Articles

  • FDA approves Exforge HCT for treatment of hypertension.  // Hem/Onc Today;6/10/2009, Vol. 10 Issue 11, p59 

    The article reports on the approval given by the U.S. Food and Drug Administration (FDA) to the antihypertensive drug Exforge HCT for patients with moderate-to-severe hypertension.

  • The year's new drugs. Rodman, Morton J. // RN;Jan80, Vol. 43 Issue 1, p97 

    Provides information on several drugs approved by the United States Food and Drug Administration in 1979. Pain relievers; Prompt relief for menstrual symptoms; Antihypertensive diuretic.

  • Olmesartan label to warn of sprue-like side effects.  // Reactions Weekly;7/13/2013, Issue 1461, p4 

    The article reports that the labels for the antihypertensive olmesartan medoxomil which are to be updated by the U.S. Food and Durgs Administration (FDA) to warn the risk of sprue-like enteropathy.

  • Fixed combination for hypertension.  // Modern Medicine;Sep95, Vol. 63 Issue 9, p27 

    Reports that the US Food and Drug Administration has approved Amlodipine/benazil HCL capsules, the first class of a new class of fixed combination antihypertensive. Availability; Addition of benazepril.

  • Two diabetes trials leave Benicar at a crossroads.  // Reactions Weekly;6/19/2010, Issue 1306, p2 

    The article deals with the safety review of the antihypertensive medication, olmesartan, being conducted by the U.S. Food and Drug Administration in June 2010.

  • Angiotensin receptor blockers and cancer: safety review.  // WHO Drug Information;2010, Vol. 24 Issue 4, p301 

    The article discusses a 2010 decision which the U.S. Food and Drug Administration made to conduct a review of the class of medications known as angiotensin receptor blockers after a study was published which suggested the medications may be associated with a small increased risk of cancer.

  • FDA Drug Approvals.  // Formulary;Jan2001, Vol. 36 Issue 1, p9 

    Introduces drugs approved by the United States Food and Drug Administration (FDA). Use of Azelastine HCL in treating symptoms of vasomotor rhinitis; Application of Enoxaparin sodium for prophylaxis of deep vein thrombosis; Efficacy of Neurontin, an antiepileptic drug.

  • Vitamin leaders sit out fight. DeNitto, Emily // Advertising Age;1/3/1994, Vol. 65 Issue 1, p32 

    Reports on efforts of vitamin supplements groups to extend the compliance date on the moratorium on vitamins, minerals and herbs marketing imposed by the Food and Drug Administration. Legislation introduced by Senator Orrin Hatch and Representative Bill Richardson; Public service announcements...

  • FDA Warns Online Pharmacies.  // Pharmaceutical Representative;Jan2010, Vol. 40 Issue 1, p11 

    The article reports on the issuance of letters by the Food and Drug Administration (FDA) to operators of online pharmacies to warn them against illegal drug sales online in the U.S.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics